Rory B Riggs Intra Cellular Therapies, Inc. (ITCI) insider trading activity

Rory B Riggs is of Intra-Cellular Therapies, Inc.. Currently has a direct ownership of 116,862 shares of ITCI, which is worth approximately $8.81 Million. The most recent transaction as insider was on Jun 28, 2024, when has been sold 262 shares (Common Stock) at a price of $68.49 per share, resulting in proceeds of $17,944. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 117K

17.46% 3M change

48.61% 12M change

Total Value Held $8.81 Million

RORY B RIGGS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 28 2024	BUY Grant, award, or other acquisition	$17,944 $68.49 p/Share	262 Added 0.22%	116,862 Common Stock
Jun 24 2024	SELL Open market or private sale	$337,193 $75.57 p/Share	4,462 Reduced 3.69%	116,600 Common Stock
Jun 24 2024	BUY Exercise of conversion of derivative security	$337,200 $16.86 p/Share	20,000 Added 14.18%	121,062 Common Stock
Jun 23 2024	BUY Exercise of conversion of derivative security	-	1,567 Added 1.53%	101,062 Common Stock
Mar 31 2024	BUY Grant, award, or other acquisition	$17,992 $69.2 p/Share	260 Added 0.26%	99,495 Common Stock
Mar 20 2024	BUY Exercise of conversion of derivative security	$371,200 $18.56 p/Share	20,000 Added 16.77%	99,235 Common Stock
Dec 31 2023	BUY Grant, award, or other acquisition	$17,976 $71.62 p/Share	251 Added 0.32%	79,235 Common Stock
Sep 30 2023	BUY Grant, award, or other acquisition	$17,971 $52.09 p/Share	345 Added 0.43%	78,984 Common Stock
Jun 30 2023	BUY Grant, award, or other acquisition	$17,666 $63.32 p/Share	279 Added 0.35%	78,639 Common Stock
Mar 31 2023	BUY Grant, award, or other acquisition	$16,948 $54.15 p/Share	313 Added 0.4%	78,360 Common Stock
Dec 30 2022	BUY Grant, award, or other acquisition	$16,987 $52.92 p/Share	321 Added 0.41%	78,047 Common Stock
Sep 30 2022	BUY Grant, award, or other acquisition	$16,983 $46.53 p/Share	365 Added 0.47%	77,726 Common Stock
Jun 30 2022	BUY Grant, award, or other acquisition	$16,496 $57.08 p/Share	289 Added 0.37%	77,361 Common Stock
Mar 31 2022	BUY Grant, award, or other acquisition	$15,726 $61.19 p/Share	257 Added 0.33%	77,072 Common Stock
Dec 31 2021	BUY Grant, award, or other acquisition	$15,702 $52.34 p/Share	300 Added 0.39%	76,815 Common Stock
Sep 30 2021	BUY Grant, award, or other acquisition	$15,732 $37.28 p/Share	422 Added 0.55%	76,515 Common Stock
Jun 30 2021	BUY Grant, award, or other acquisition	$15,716 $40.82 p/Share	385 Added 0.5%	76,093 Common Stock
May 27 2021	BUY Exercise of conversion of derivative security	-	13,767 Added 15.39%	75,708 Common Stock
Mar 31 2021	BUY Grant, award, or other acquisition	$15,744 $33.93 p/Share	464 Added 0.74%	61,941 Common Stock
Dec 31 2020	BUY Grant, award, or other acquisition	$15,741 $31.8 p/Share	495 Added 0.8%	61,477 Common Stock
Sep 30 2020	BUY Grant, award, or other acquisition	$15,730 $25.66 p/Share	613 Added 1.0%	60,982 Common Stock

Also insider at

RPRX

Royalty Pharma plc Healthcare

Director

FGEN

FIBROGEN INC Healthcare

Director

CLXT

Calyxt, Inc. Consumer Defensive

Chief Executive Officer

RBR

Rory B Riggs

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ITCI shares.

Notify only if

Value

Insider Trading

Get notified when an Intra Cellular Therapies, Inc. insider buys or sells ITCI shares.

Notify only if

Operation

Value

Type

News

Receive news related to Intra-Cellular Therapies, Inc.

Track Activities on ITCI

Account